Pulmonary arteriovenous malformation in children

Area of Science:

• Vascular Medicine
• Pediatric Cardiology
• Genetics

Background:

• Pulmonary arteriovenous malformations (PAVMs) are uncommon vascular anomalies, frequently associated with hereditary hemorrhagic telangiectasia (HHT).
• Many patients with PAVMs are asymptomatic upon diagnosis, masking potential risks.
• Untreated PAVMs, particularly larger ones, can lead to severe complications like hypoxemia, stroke, cerebral abscess, and hemoptysis.

Purpose of the Study:

• To highlight the importance of early screening for PAVMs in at-risk pediatric populations.
• To emphasize the necessity of ongoing surveillance for timely detection and intervention.
• To discuss the management of PAVMs and potential complications.

Main Methods:

• Review of existing literature on PAVMs in children with HHT.
• Analysis of clinical presentation, diagnostic approaches, and treatment outcomes.
• Discussion of screening protocols and long-term follow-up strategies.

Main Results:

• PAVMs are predominantly found in children with HHT, often without initial symptoms.
• Embolization is an effective treatment for larger PAVMs, but reperfusion can occur post-procedure.
• Early detection through screening and consistent surveillance are key to preventing severe outcomes.

Conclusions:

• Screening for PAVMs is recommended for asymptomatic children with HHT or those at risk.
• Long-term surveillance is essential for identifying and managing PAVMs to mitigate risks.
• Proactive management of PAVMs can significantly improve patient outcomes and prevent life-threatening complications.